The NZX acquired the active funds manager from Craigs Investment Partners in a deal worth more than $30m.
The company’s future dividend policy, which has been suspended since 2023, is based on cash generation.
Kiwi utilities-focused SaaS company says potential tariffs won't hurt its chances in the United States.
Listed transport heavyweight boosts revenue and profit while noting highly uncertain outlook.
The ASX-listed bioscience company posted a strong second half and its guidance for 2026 is bullish.
Hiving off a minority stake in Highbrook Business Park seen as a more attractive option than an equity issue.
Trade software-as-a-service business reported annual loss of $3.5m in FY25.
The cervical cancer screening device company's board warned in November it might not survive without raising more cash.
The company completed a $1b capital raise earlier this year to pay down debt.
NZX-listed waste management company landed a $40m contract earlier this month.